Anal Chim Acta. 2026 Jun 08. pii: S0003-2670(26)00344-2. [Epub ahead of print]1402
345394
BACKGROUND: Therapeutic drug monitoring (TDM) of tyrosine kinase inhibitors (TKIs) is essential for individualized dosing due to their narrow therapeutic windows and pronounced pharmacokinetic variability. However, routine TDM is still hindered by sample preparation strategies that rely on labor-intensive workflows, high consumption of toxic organic solvents, and poor procedural standardization, limiting their suitability for high-throughput and green clinical analysis. Therefore, there is a clear need for a standardized, eco-friendly, and ready-to-use sample preparation strategy that enables robust and routine determination of TKIs in plasma.
RESULTS: Herein, a standardized, ready-to-use extraction device inspired by pharmaceutical blister packaging was developed for the determination of nine TKIs in human plasma. Hydrophobic natural deep eutectic solvent (NADES, menthol-thymol, 2:1) was pre-impregnated into polypropylene fiber (PPF) and sealed as individual consumable units, enabling a unit-supported liquid-phase microextraction (NADES-PPF-SLPME) strategy suitable for high-throughput operation. Density functional theory revealed that extraction was governed by synergistic hydrogen bonding and π-π stacking interactions between NADES and TKIs. Under Box-Behnken optimized conditions, the method exhibited wide linearity (R2 ≥ 0.990), low limits of quantification (0.2-1.0 ng/mL), satisfactory recoveries (86.64-110.30%), and acceptable precision (RSD <14.10%). The standardized units retained extraction capacity above 86.47% after three months of storage and enabled reliable quantification of TKIs in real clinical plasma samples.
SIGNIFICANCE: This work introduces a robust "prepare-in-advance, use-on-demand" NADES-based microextraction strategy that integrates standardization, operational robustness, high throughput, and green analytical chemistry. By eliminating on-site solvent preparation and minimizing solvent consumption, the proposed method offers an eco-friendly and operationally simple solution for routine clinical TDM of TKIs in plasma.
Keywords: Liquid chromatography-tandem mass spectrometry (LC-MS/MS); Liquid-phase microextraction (LPME); Natural deep eutectic solvent (NADES); Polypropylene fiber (PPF); Therapeutic drug monitoring (TDM); Tyrosine kinase inhibitors (TKI)